Switch to:
Neptune Technologies & Bioressources Inc (NAS:NEPT)
Net Interest Income
$4.10 Mil (TTM As of May. 2014)

Net interest income is the income earned by banks from the fund they have on their balance sheet. Neptune Technologies & Bioressources Inc's net interest income for the three months ended in May. 2014 was $4.16 Mil. Its net interest income for the trailing twelve months (TTM) ended in May. 2014 was $4.10 Mil.

Neptune Technologies & Bioressources Inc's quarterly net interest income increased from Nov. 2013 ($-0.50 Mil) to Feb. 2014 ($0.50 Mil) and increased from Feb. 2014 ($0.50 Mil) to May. 2014 ($4.16 Mil).

Neptune Technologies & Bioressources Inc's annual net interest income increased from Feb. 2012 ($-0.14 Mil) to Feb. 2013 ($-0.01 Mil) and increased from Feb. 2013 ($-0.01 Mil) to Feb. 2014 ($0.01 Mil).


Definition

Income earned by banks from the fund they have on their balance sheet. These funds can be from customers' deposit, bank's own equity or borrowed.

Neptune Technologies & Bioressources Inc Net Interest Income for the trailing twelve months (TTM) ended in May. 2014 was -0.041586073501 (Aug. 2013 ) + -0.50469924812 (Nov. 2013 ) + 0.495949594959 (Feb. 2014 ) + 4.15512465374 (May. 2014 ) = $4.10 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Neptune Technologies & Bioressources Inc Annual Data

May04May05May06May07May08Feb10Feb11Feb12Feb13Feb14
IS_NetInterestIncome -0.68-0.82-0.91-0.50-0.36-0.55-0.43-0.14-0.010.01

Neptune Technologies & Bioressources Inc Quarterly Data

Feb12May12Aug12Nov12Feb13May13Aug13Nov13Feb14May14
IS_NetInterestIncome -0.03-0.22-0.400.350.260.04-0.04-0.500.504.16
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK